featured
Potential Signals for Suicidal and Self-Injurious Adverse Drug Reactions Associated With Semaglutide Use
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality
JAMA Netw Open 2024 Aug 01;7(8)e2423385, G Schoretsanitis, S Weiler, C Barbui, E Raschi, C GastaldonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.